Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
- 5 April 2004
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (15) , 5583-5588
- https://doi.org/10.1073/pnas.0401381101
Abstract
Receptor tyrosine kinases of the Eph family are up-regulated in different types of cancer. EphB4 and its ligand ephrin-B2 have been linked to breast cancer, but little is known about how this receptor–ligand complex may contribute to oncogenesis. The Eph receptors transmit forward signals via their kinase domain and reverse signals via their transmembrane ephrin-B ligands. Therefore, we used EphB4 that were lacking the kinase domain and tagged with EGFP (EphB4ΔC-EGFP) to differentiate between EphB4 and ephrin-B2 signaling. Interestingly, we found that expression of EphB4ΔC-EGFP in breast cancer cells increases tumor growth in a mouse xenograft model. Given the undetectable EphB4 activation in the tumor cells, dominant negative effects of EphB4ΔC-EGFP are unlikely to explain the increased tumor growth. Examination of the tumors revealed that ephrin-B2 is primarily expressed in the vasculature and that the EphB4ΔC-EGFP tumors have a higher blood content than control tumors, concomitant with increased size of blood vessels. In support of an effect on the vasculature, the extracellular domain of EphB4 attracts endothelial cells in vitro and stimulates endothelial cell invasion, survival, and proliferation, all crucial factors for angiogenesis. These results support a model in which EphB4 promotes tumor growth by stimulating angiogenesis through ephrin-B2.Keywords
This publication has 42 references indexed in Scilit:
- `Eph'ective signaling: forward, reverse and crosstalkJournal of Cell Science, 2003
- Ephrin-B1 Reverse Signaling Activates JNK through a Novel Mechanism That Is Independent of Tyrosine PhosphorylationJournal of Biological Chemistry, 2003
- Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cellsJournal of Cell Science, 2003
- Molecular regulation of vessel maturationNature Medicine, 2003
- EphB ligand, ephrinB2, suppresses the VEGF‐ and angiopoietin‐1‐induced Ras/mitogen‐activated protein kinase pathway in venous endothelial cellsThe FASEB Journal, 2002
- EphrinB Phosphorylation and Reverse SignalingMolecular Cell, 2002
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000
- Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1Science, 1999
- The AP-1 site and MMP gene regulation: What is all the fuss about?Matrix Biology, 1997
- Expression of the Receptor Protein Tyrosine Kinasemyk-1/htkin Normal and Malignant Mammary EpitheliumBiochemical and Biophysical Research Communications, 1996